ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
오렌시아(아바타셉트) 시장 규모는 향후 몇 년간 급속한 성장을 기록할 것으로 예상됩니다. 예측 기간 동안의 성장은 맞춤형 의약품의 채택 증가, 덜 침습적인 피하 투여에 대한 환자의 선호도 증가, 의료 서비스 접근성이 향상된 신흥 시장의 확대, 우수한 효능 및 안전성 프로필로 인한 생물학적 치료제로의 지속적인 전환에 기인할 수 있습니다. 예측 기간 동안의 주요 동향으로는 선진 시장의 보험 적용 범위 개선, 바이오시밀러 및 비용 효율적인 대체품으로의 전환, 파트너십, 제품 승인 등이 있습니다.
자가 면역 질환의 유병률이 증가함에 따라 오렌시아(아바타셉트) 시장의 성장이 촉진될 것으로 예상됩니다. 자가 면역 질환은 면역 체계가 신체의 세포, 조직 또는 장기를 잘못 공격하여 염증과 손상을 일으키는 질환입니다. 이는 유전적 요인과 환경적 요인이 모두 원인이 되는 류마티스 관절염 및 다발성 경화증과 같은 만성 질환으로 이어집니다. 자가면역질환의 증가는 유전적 소인, 환경적 요인, 인식 및 진단 능력의 향상으로 인해 더 많은 사례가 발견되고 있기 때문으로 보입니다. 오렌시아(아바타셉트)는 선택적 T 세포 공동 자극 억제를 통해 면역 반응을 조절하여 염증을 완화하고 면역 체계가 건강한 조직을 공격하는 것을 방지함으로써 자가면역질환을 관리하는 데 도움을 줍니다. 예를 들어, 2024년 3월, 미국에 본사를 둔 비영리 단체인 National Health Council은 자가 면역 질환이 약 5천만 명의 미국인에게 영향을 미치고 있으며, 그 사례가 매년 3-12% 씩 증가하고 있다고 보고했습니다. 전 세계적으로 다발성 경화증 사례는 지난 10년 동안 30% 증가했습니다. 그 결과, 자가 면역 질환의 유병률이 증가하면서 오렌시아(아바타셉트) 시장의 성장이 촉진되고 있습니다.
맞춤형 의약품의 부상은 오렌시아(아바타셉트) 시장의 성장을 촉진할 것으로 예상됩니다. 맞춤형 의약품은 가장 정확하고 효과적인 결과를 얻기 위해 개인의 고유한 유전적 구성, 환경 및 생활 방식에 맞게 치료 및 건강 관리 전략을 맞춤화하는 것을 의미합니다. 맞춤형 의약품의 성장은 유전체 기술의 발전, 분자 생물학에 대한 이해의 심화, 정밀 진단 도구의 이용 가능성 증가, 부작용을 줄이면서 환자의 치료 결과를 개선하는 표적 치료에 대한 수요에 의해 촉진되고 있습니다. 오렌시아(아바타셉트)는 자가 면역 질환과 관련된 특정 면역 체계 경로를 표적으로 함으로써 맞춤형 의약품에서 중요한 역할을 합니다. 이 약물은 환자의 고유한 면역 반응과 질병 특성에 따라 전신 부작용을 최소화하고 치료 결과를 최적화하는 맞춤형 치료 계획을 가능하게 합니다. 예를 들어, 2023년에 미국에 본사를 둔 Personalized Medicine Coalition은 2022년에 FDA가 신약의 34%에 대해 맞춤형 의약품을 승인했으며, 지난 8년 동안 신약의 최소 25%가 맞춤형 치료에 대한 승인을 받았다고 보고했습니다. 따라서 맞춤형 의약품의 부상은 오렌시아(아바타셉트) 시장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여경로(ROA)
작용기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 오렌시아(아바타셉트) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 오렌시아(아바타셉트) 시장 : 성장률 분석
세계의 오렌시아(아바타셉트) 시장 실적 : 규모와 성장(2019-2024년)
세계의 오렌시아(아바타셉트) 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 오렌시아(아바타셉트) : 전체 시장 규모(TAM)
제7장 세계 시장의 가격 분석과 예측
제8장 시장 세분화
세계의 오렌시아(아바타셉트) 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
프리필드 주사기
바이알
세계의 오렌시아(아바타셉트) 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
류마티스 관절
청소년 특발성 관절염
건선성 관절염
세계의 오렌시아(아바타셉트) 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
제9장 임상적응증 세계 시장 역학
약제의 부작용
임상적응증의 발병률과 유병률
제10장 지역별, 국가별 분석
세계의 오렌시아(아바타셉트) 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 오렌시아(아바타셉트) 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 프로파일
오렌시아(아바타셉트) 시장 : 경쟁 구도
오렌시아(아바타셉트) 시장 : 기업 프로파일
Bristol-Myers Squibb(BMS)
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 전략
오렌시아(아바타셉트) 시장(2029년) : 새로운 기회를 제공하는 국가
오렌시아(아바타셉트) 시장(2029년) : 새로운 기회를 제공하는 부문
오렌시아(아바타셉트) 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
HBR
영문 목차
영문목차
Orencia (abatacept) is a prescription medication used to treat certain autoimmune diseases. It is classified as a selective T-cell co-stimulation modulator, which works by suppressing overactive immune responses that cause inflammation and tissue damage.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The key formulations of orencia (abatacept) include prefilled syringes and vials. A prefilled syringe contains a single dose of the medication and is used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis. These formulations are used for various applications, including rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis, and are distributed through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies.
The orencia (abatacept) market research report is one of a series of new reports from The Business Research Company that provides orencia (abatacept) market statistics, including orencia (abatacept) industry global market size, regional shares, competitors with a orencia (abatacept) market share, detailed orencia (abatacept) market segments, market trends and opportunities, and any further data you may need to thrive in the orencia (abatacept) industry. This orencia (abatacept) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The orencia (abatacept) market size is expected to see rapid growth in the next few years. It will grow to $4,733.5 million in 2029 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine, growing patient preference for less invasive subcutaneous administration, expansion in emerging markets with rising healthcare access, the ongoing shift toward biologic therapies due to their superior efficacy and safety profiles. Major trends in the forecast period include improving reimbursement scenarios in developed markets, a shift towards biosimilars and cost-effective alternatives, partnerships, product approvals.
The increasing prevalence of autoimmune disorders is expected to drive the growth of the orencia (abatacept) market in the future. Autoimmune disorders occur when the immune system mistakenly attacks the body's own cells, tissues, or organs, resulting in inflammation and damage. This leads to chronic conditions like rheumatoid arthritis and multiple sclerosis, which have causes rooted in both genetic and environmental factors. The rise in autoimmune disorders is attributed to factors such as genetic predisposition, environmental triggers, and greater awareness and diagnosis, leading to more cases being identified. Orencia (abatacept) aids in managing autoimmune diseases by modulating the immune response through selective T-cell costimulation inhibition, thus reducing inflammation and preventing the immune system from attacking healthy tissues. For example, in March 2024, the National Health Council, a U.S.-based non-profit organization, reported that autoimmune diseases affect approximately 50 million Americans, with cases increasing by 3-12% annually. Globally, multiple sclerosis cases rose by 30% in 2022 compared to the previous decade. As a result, the increasing prevalence of autoimmune disorders is contributing to the growth of the orencia (abatacept) market.
The rise of personalized medicine is expected to fuel the growth of the orencia (abatacept) market. Personalized medicine involves tailoring treatment and healthcare strategies to an individual's unique genetic makeup, environment, and lifestyle to achieve the most precise and effective outcomes. The growth of personalized medicine is driven by advancements in genomic technologies, a better understanding of molecular biology, the increased availability of precision diagnostic tools, and the demand for targeted therapies that improve patient outcomes while reducing side effects. Orencia (abatacept) plays a role in personalized medicine by targeting specific immune system pathways involved in autoimmune diseases, allowing for customized treatment plans that minimize systemic side effects and optimize therapeutic results based on a patient's unique immune response and disease characteristics. For example, in 2023, the Personalized Medicine Coalition, a U.S.-based organization, reported that in 2022, the FDA approved personalized medicines for 34% of new drugs, and over the prior eight years, at least 25% of new drugs had received approval for personalized treatment. Therefore, the rise of personalized medicine is driving the orencia (abatacept) market.
A key trend in the orencia (abatacept) market is the focus on developing innovative drugs to enhance treatment effectiveness, improve patient outcomes, and address unmet needs in managing autoimmune diseases. Abatacept is a biologic medication used in the treatment of juvenile psoriatic arthritis (JPsA), a rare autoimmune condition affecting children and adolescents, causing joint inflammation and skin lesions. For example, in October 2023, Bristol Myers Squibb, a U.S.-based pharmaceutical company, announced that the FDA approved the Biologics Licensing Application (sBLA) for abatacept (Orencia) to treat juvenile psoriatic arthritis (JPsA) in patients aged 2 to 17 years. This approval was based on controlled studies involving both adults and children, utilizing pharmacokinetic data from studies on adults with rheumatoid arthritis and psoriatic arthritis, as well as safety data from clinical trials involving children aged 2 to 17 years with polyarticular juvenile idiopathic arthritis (JIA).
Key player operating in the orencia (abatacept) market is Bristol-Myers Squibb (BMS).
North America was the largest region in the orencia (abatacept) market in 2024. The regions covered in orencia (abatacept) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the orencia (abatacept) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The orencia market consists of sales of abatacept-based biologic therapies, injectable and intravenous solutions, and immunomodulatory treatments. Values in this market are 'factory gate' values, which represent the value of goods sold by the manufacturers or creators of the goods, whether to other entities (such as wholesalers, distributors, and healthcare providers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Orencia (Abatacept) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on orencia (abatacept) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for orencia (abatacept) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orencia (abatacept) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Prefilled Syringe; Vial
2) By Application: Rheumatoid Arthritis; Juvenile Idiopathic Arthritis; Psoriatic Arthritis
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Orencia (Abatacept) Market Characteristics
3. Orencia (Abatacept) Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Orencia (Abatacept) Market Trends And Strategies
5. Orencia (Abatacept) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Orencia (Abatacept) Growth Analysis And Strategic Analysis Framework
6.1. Global Orencia (Abatacept) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Orencia (Abatacept) Market Growth Rate Analysis
6.4. Global Orencia (Abatacept) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Orencia (Abatacept) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Orencia (Abatacept) Total Addressable Market (TAM)
7. Global Orencia (Abatacept) Market Pricing Analysis & Forecasts
8. Orencia (Abatacept) Market Segmentation
8.1. Global Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prefilled Syringe
Vial
8.2. Global Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
8.3. Global Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
9. Global Orencia (Abatacept) Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Orencia (Abatacept) Market Regional And Country Analysis
10.1. Global Orencia (Abatacept) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Orencia (Abatacept) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
